European regulator to explain blood clot probe

On Tuesday, a senior EMA official said there was a causal link between the AstraZeneca vaccine and the rare blood clots

European regulator to explain blood clot probe

File photo for representation.

London, April 7

The European Medicines Agency will announce the conclusions of its investigation into the possible connection between AstraZeneca’s coronavirus vaccine and rare blood clots later Wednesday.

On Tuesday, a senior EMA official said there was a causal link between the AstraZeneca vaccine and the rare blood clots that have been seen in dozens of people worldwide, among the tens of millions who have received at least one dose.

In comments to Rome’s Il Messaggero newspaper, Marco Cavaleri, head of health threats and vaccine strategy at the Amsterdam-based agency, said “it is becoming more and more difficult to affirm that there isn’t a cause-and-effect relationship between AstraZeneca vaccines and the very rare cases of blood clots associated with a low level of platelets”.

But Cavaleri acknowledged the agency had not yet figured out how exactly the vaccine might be causing these rare side effects. AP

Top Stories

Oxygen leak kills 24 patients in Nashik

Oxygen leak kills 24 patients in Nashik

Centre boosts O2 supply as states raise alarm

Covaxin kills double mutant strain: ICMR

Covaxin kills double mutant strain: ICMR

Phase 3 study shows 100% efficacy against severe Covid, 78%...

Cities

View All